Labiotech.eu

News and Trends 23 Mar 2015

Life Sciences have a new big player: Joint Polish Investment Fund Management

Poland’s first Institutional Venture Capital Fund dedicated to Life Sciences announced today the first closing of its new venture capital fund at €38.5M. Joint Polish Investment Fund Management (JPIF), headed by Dr. Marek Orłowski, is the first institutional venture capital fund operating out of Poland that is completely dedicated to life science investments. The fund […]

March 23, 2015 - 3 minutesmins - By Lourdes Riquelme

AOP Orphan Pharmaceuticals Confluence Pharmaceuticals Fragile X

News and Trends 23 Mar 2015

AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome

AOP Orphan Pharmaceuticals and Confluence Pharmaceuticals, signed today a definitive agreement to co-develop and market Confluence’s lead asset, a product for the treatment of Fragile X Syndrome in Europe and the Middle East. Confluence is an American biopharmaceutical company focused on developing therapeutic treatments for Fragile X Syndrome and Autism Spectrum Disorders. The company has […]

March 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 23 Mar 2015

A Vaccine against Placental Malaria made with ExpreS2ion’s Protein Expression Technology

University of Copenhagen released a vaccine candidate against the form of malaria that strikes pregnant women, for testing in humans. The vaccine candidate contains a malaria antigen made with ExpreS2ion Biotechnologies’ protein expression technology, ExpreS2. This vaccine candidate results from many years of research done by Professor Ali Salanti and his team at the Department […]

March 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 21 Mar 2015

#BioFigures: 12 Key French Players launch New Immunotechnology Reference Center MI-mabs

WHO? MI-mAbs (“MI” for Marseille Immunopole and “mAbs” for monoclonal antibody) is a new immunotechnology center headed by Prof. Francois Romagne, located at the heart of the Marseille-Luminy Scientific and Technological Park, and designed to accelerate the development of new immunotherapy antibodies against cancer and inflammatory disease. Prize-Winner of the program “Investments for the Future” […]

March 21, 2015 - 2 minutesmins - By Marie Godar

News and Trends 20 Mar 2015

Optibrium introduces the lastest version of StarDrop

Cambridge-based Optibrium has launched of version 6.1 of its StarDrop platform to guide researchers in the design of high quality compounds in drug discovery, agrochemicals and other chemistry fields. The latest release introduces the Matsy technology, based on matched molecular series analysis, which proposes strategies for chemical substitutions to optimise compound activity. Also included is […]

March 20, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 20 Mar 2015

Let’s Focus on Calypso Biotech, a New Promising Startup that Concentrates on Niche Gastro-intestinal Diseases

Last week, I was in Bio Spring Europe and I met Alain Vicari, Calypso Biotech’s CEO: What is Calypso Biotech? Calypso Biotech discovers and develops antibody therapies for indications in gastro-intestinal diseases. The company tackles on niche diseases, with therapeutic antibodies against difficult targets. Calypso was founded in Geneva, in 2013, as a spin-off of […]

March 20, 2015 - 3 minutesmins - By Julie Lellouche

microbiome microbiomics seventure partners

News and Trends 19 Mar 2015

The World’s First €100M Microbiome-focused Venture Fund opened in France

Microbiomics is one of the next big trends in the Biotech industry. Using bacteria present in our guts to cure people has shown more and more potential. The VC industry is now interested in this field. Seventure Partners, the second largest Biotech Venture capital company and the world’s first €100M fund focused on Microbiome is now opening in […]

March 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 19 Mar 2015

Syngenta corn trait expansion further continues thanks the Vietnamese approval

A few days ago, Syngenta announced that the Vietnamese Ministry of Natural Resources and Environment has approved its Bt11 x GA21 double stack corn seed for commercial cultivation in the country. Syngenta, one of the world’s leading companies in the field of Green Biotechnology, have more than 28,000 employees in over 90 countries. The company […]

March 19, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 18 Mar 2015

Novartis’ Jakavi receives European Commission approval

Novartis received the approval from the European Commission for Jakavi (ruxolitinib) for the treatment of adult patients with Polycythemia Vera (PV) who are resistant to or intolerant of hydroxyurea. Jakavi is the first targeted treatment approved by the European Commission for these patients. PV is a rare and incurable blood cancer associated with an overproduction […]

March 18, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 18 Mar 2015

Valneva penetrates Chinese Market thanks to a license agreement

A few months ago, the article “An Anglo-French Partnership To Cure Hepatitis B” related Valneva partnerships with Immune Targeting Systems. Today Valneva, a leading pure play vaccines biotech company is again on the front of the stage by announcing the exclusive license agreement with the Chinese company Jianshun Biosciences to commercialize Valneva’s EB66 cell line […]

March 18, 2015 - 2 minutesmins - By Joachim Eeckhout

Inside Labiotech 17 Mar 2015

Labiotech: Taking it to the next level

Today is an exciting day for us! In its short history, Labiotech has brought a fresh dynamic and original concepts to the Biotech media industry. So far, 5 Tours have been accomplished worldwide with 5 more to come still in 2015. For the first time, Labiotech has filmed entire biotech companies and ecosystems, to cover the latest […]

March 17, 2015 - 2 minutesmins - By Joachim Eeckhout

New oncology neoliquid neoplus cancer diagnosis

News and Trends 17 Mar 2015

New Oncology finances its Genetic Test for Cancer Diagnosis

New Oncology completed a financing round to prepare the market launch of NEOliquid, a non-invasive blood test that identifies therapeutically actionable genome alterations in the circulating free tumor DNA (ctDNA) of cancer patients. New Oncology’s pan-cancer diagnostic platform NEOplus reliably detects actionable genome alterations from one single patient sample with short turn-around times. In contrast to […]

March 17, 2015 - 2 minutesmins - By Lourdes Riquelme

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Life Sciences have a new big player: Joint Polish Investment Fund Management

AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome

A Vaccine against Placental Malaria made with ExpreS2ion’s Protein Expression Technology

#BioFigures: 12 Key French Players launch New Immunotechnology Reference Center MI-mabs

Optibrium introduces the lastest version of StarDrop

Let’s Focus on Calypso Biotech, a New Promising Startup that Concentrates on Niche Gastro-intestinal Diseases

The World’s First €100M Microbiome-focused Venture Fund opened in France

Syngenta corn trait expansion further continues thanks the Vietnamese approval

Novartis’ Jakavi receives European Commission approval

Valneva penetrates Chinese Market thanks to a license agreement

Labiotech: Taking it to the next level

New Oncology finances its Genetic Test for Cancer Diagnosis

Subscribe to our newsletter to get the latest biotech news!